Status:
NOT_YET_RECRUITING
Daily Tadalafil in Diabetic ED Patients
Lead Sponsor:
South Valley University
Conditions:
Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Eligibility:
MALE
30-60 years
Phase:
NA
Brief Summary
This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and p...
Eligibility Criteria
Inclusion
- Male patients aged between 30 and 60 yearsز Diagnosed with diabetes mellitus Suffering from erectile dysfunction No history of hypertension or other systemic diseases
Exclusion
- History of pelvic trauma or major pelvic surgery Pacientes con hipogonadismo o hiperprolactinemia Chronic liver disease or cardiovascular disorders Chronic use of central nervous system drugs, anti-androgenic drugs, or Tramadol Smokers Non-vasculogenic erectile dysfunction Known allergy to tadalafil
Key Trial Info
Start Date :
May 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06962462
Start Date
May 5 2025
End Date
August 30 2025
Last Update
May 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.